Fibroscan ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
93	Primary biliary cholangitis	1
171	Wilson disease	1

93. Primary biliary cholangitis

---

Clinical trials : 282 /  Drugs : 245 - (DrugBank : 56) / Drug target genes : 35 - Drug target pathways : 113

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02931513 (ClinicalTrials.gov)	September 2016	11/10/2016	sCD163 in PBC Patients - Assessment of Treatment Response	Macrophage Activation Marker sCD163 in PBC Patients - Assessment of Treatment Response to UDCA	Primary Biliary Cirrhosis;Liver Inflammation;Ursodeoxycholic Acid	Other: Blood samples;Device: Fibroscan;Other: Questionnaires;Biological: Liver biopsy	University of Aarhus	NULL	Recruiting	18 Years	N/A	All	40		Denmark

171. Wilson disease

---

Clinical trials : 68 /  Drugs : 79 - (DrugBank : 17) / Drug target genes : 3 - Drug target pathways : 28

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02702765 (ClinicalTrials.gov)	February 2016	26/2/2016	sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis	Macrophages and the Macrophage Activation Markers sCD163 and Mannose Receptor (sMR) in Patients With Wilsons Disease - Associations With Liver Disease Severity and Fibrosis	Wilsons Disease	Procedure: Fibroscan;Procedure: Ultrasound;Drug: Galactose;Procedure: Liver biopsy;Procedure: Functional hepatic nitrogen clearance	University of Aarhus	Aarhus University Hospital	Active, not recruiting	18 Years	100 Years	All	33	N/A	Denmark